| Literature DB >> 27707777 |
P Malfertheiner1, F Megraud2, C A O'Morain3, J P Gisbert4,5, E J Kuipers6, A T Axon7, F Bazzoli8, A Gasbarrini9, J Atherton10, D Y Graham11, R Hunt12,13, P Moayyedi14, T Rokkas15, M Rugge16, M Selgrad17, S Suerbaum18, K Sugano19, E M El-Omar20.
Abstract
Important progress has been made in the management of Helicobacter pylori infection and in this fifth edition of the Maastricht Consensus Report, key aspects related to the clinical role of H. pylori were re-evaluated in 2015. In the Maastricht V/Florence Consensus Conference, 43 experts from 24 countries examined new data related to H. pylori in five subdivided workshops: (1) Indications/Associations, (2) Diagnosis, (3) Treatment, (4) Prevention/Public Health, (5) H. pylori and the Gastric Microbiota. The results of the individual workshops were presented to a final consensus voting that included all participants. Recommendations are provided on the basis of the best available evidence and relevance to the management of H. pylori infection in the various clinical scenarios. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.Entities:
Keywords: GASTRITIS; HELICOBACTER PYLORI; HELICOBACTER THERAPY
Mesh:
Substances:
Year: 2016 PMID: 27707777 DOI: 10.1136/gutjnl-2016-312288
Source DB: PubMed Journal: Gut ISSN: 0017-5749 Impact factor: 23.059